FDA Inspection
SeQuent Research LimitedSeQuent Research Limited – FDA Inspection, Oct 12, 2018
Record Details
This FDA Inspection record concerns SeQuent Research Limited, with an inspection on October 12, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 06a7d248-f057-4315-a90a-4bf4e35ca2ae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1068495
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SeQuent Research Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2025 | Not classified | Office of Inspections and Investigations | |
| February 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SeQuent Research Limited
- FDA Inspection 1286970 - 2025-09-03
- FDA Inspection 1121166 - 2020-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.